ODDB.org: Open Drug Database

Home - 66472 - 01 - 001

Maviret Filmtabletten - 84

Swissmedic Key	66472001 PP	Registration Holder	AbbVie AG
Name	Maviret Filmtabletten	Date of registration	22.09.2017
		Introduction of Sequence	22.09.2017
ATC-Classification	Glecaprevir and Pibrentasvir (J05AP57)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.03.	Show package size	84
Index Therapeuticus (Swissmedic)	08.03.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	14407.03	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	15027.85
Feedback	FB
GTIN	7680664720013	Medication Code	Synthetika
Pharmacode	7226233	Disponibility

Composition

glecaprevirum 100 mg, pibrentasvirum 40 mg, copovidonum K 28, tocofersolanum, silica colloidalis anhydrica, propylenglycoli monooctanoas, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: hypromellosum, lactosum monohydricum 7.87 mg, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 2.6 mg.

Packungsbestandteile

Active Agent	Dose
Glecaprevirum	100 mg
Pibrentasvirum	40 mg

BAG: Active Agent	Dose
Glecaprevirum	100 mg
Pibrentasvirum	40 mg

Inactive agents	Dose	additional_information
(Rubrum)
Carmellosum Natricum Conexum
Copovidonum K	28
E 171		color.
E 172		color.
Hypromellosum		Überzug
Lactose Monohydrate	7.87 mg
Macrogol	3350
Natrii Stearylis Fumaras
Pro Compresso Obducto
Propylenglycoli Monooctanoas
Silica Colloidalis Anhydrica
Tocofersolanum

Source

Data was imported : 05.08.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH